Increased clinical trial enrollment among adolescent and young adult cancer patients between 2006 and 2012–2013 in the United States

Stagnant outcomes for adolescents and young adults (AYAs) 15–39 years of age with cancer are partly attributed to poor enrollment onto clinical trials. Initiatives have focused on increasing accrual, but changes at the population‐level are unknown. We examined patterns of clinical trial participation over time in AYA patients with cancer.

[1]  S. Mercadal,et al.  A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial , 2020, Cancer medicine.

[2]  Teresa P. Edwards,et al.  Patient/Provider Discussions About Clinical Trial Participation and Reasons for Nonparticipation Among Adolescent and Young Adult Women with Cancer. , 2020, Journal of adolescent and young adult oncology.

[3]  Nehal B. Trivedi,et al.  Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: Identifying opportunities for intervention , 2019, Cancer.

[4]  M. Ward,et al.  Nonmetropolitan residence and other factors affecting clinical trial enrollment for adolescents and young adults with cancer in a US population–based study , 2019, Cancer.

[5]  T. Keegan,et al.  Adolescent angst: enrollment on clinical trials. , 2018, Hematology. American Society of Hematology. Education Program.

[6]  J. Malvar,et al.  A prospective, observational cohort study comparing cancer clinical trial availability and enrollment between early adolescents/young adults and children , 2018, Cancer.

[7]  C. Printz.  Organizations and agencies launch efforts to improve research in adolescent and young adult cancers , 2018, Cancer.

[8]  J. Beaumont,et al.  Clinical research participation among adolescent and young adults at an NCI-designated Comprehensive Cancer Center and affiliated pediatric hospital , 2017, Supportive Care in Cancer.

[9]  Mike G Martin,et al.  Clinical Trial Availability in Adolescent and Young Adult Patients with Non-Hodgkin Lymphoma , 2016 .

[10]  Elisabeth Heath,et al.  Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer. , 2016, Cancer control : journal of the Moffitt Cancer Center.

[11]  S. Schwartz,et al.  Knowledge of Clinical Trial Availability and Reasons for Nonparticipation Among Adolescent and Young Adult Cancer Patients: A Population-based Study , 2016, American journal of clinical oncology.

[12]  H. Bang,et al.  Early impact of the Patient Protection and Affordable Care Act on insurance among young adults with cancer: Analysis of the dependent insurance provision , 2016, Cancer.

[13]  B. Pollock,et al.  Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program. , 2016, Journal of oncology practice.

[14]  L. Ries,et al.  Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults , 2016, Cancer.

[15]  D. R. Lewis,et al.  Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future , 2016, Cancer.

[16]  D. Deapen,et al.  Case‐linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute‐Designated comprehensive cancer center , 2015, Cancer.

[17]  D. Freyer,et al.  Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging Strategies. , 2015, Seminars in oncology.

[18]  N. Seibel,et al.  The Clinical Trials Gap for Adolescents and Young Adults with Cancer: Recent Progress and Conceptual Framework for Continued Research , 2015, Current Pediatrics Reports.

[19]  J. Perentesis,et al.  Children's Oncology Group's 2013 blueprint for research: Adolescent and young adult oncology , 2013, Pediatric blood & cancer.

[20]  S. Schwartz,et al.  Impact of cancer on work and education among adolescent and young adult cancer survivors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  L. Harlan,et al.  Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Webber.  Center , 2011 .

[23]  J. Armitage.  Early-stage Hodgkin's lymphoma. , 2010, The New England journal of medicine.

[24]  W. McCaskill-Stevens,et al.  Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  A. Bleyer,et al.  The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[26]  A. Bleyer,et al.  The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[27]  B. Weiner,et al.  Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program. , 2012, Contemporary clinical trials.

[28]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[29]  A. Bleyer,et al.  Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. , 2006 .

[30]  W. J. Hadden,et al.  A Comparison of , 1971 .